Page last updated: 2024-08-20

dextrothyroxine and ribavirin

dextrothyroxine has been researched along with ribavirin in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (33.33)24.3611
2020's4 (66.67)2.80

Authors

AuthorsStudies
Dranchak, PK; Huang, R; Inglese, J; Lamy, L; Oliphant, E; Queme, B; Tao, D; Wang, Y; Xia, M1
Amin, B; Jariwala, S; Patel, P; Rampur, L; Rosenstreich, DL1
Anjum, AA; Ashraf, M; Azeem, S; Hameed, R; Rasheed, MA1
Wen, S; Xu, X; Yadav, AK; Yu, L1
Abo El Kheir, NY; Alegezy, M; Alhawarey, A; Besheer, T; El-Bendary, M; El-Emshaty, WM; El-Gilany, AH; El-Mesery, A; Elalfy, H; Elhadidy, T; Hewidy, AA; Neamatallah, MAM; Raafat, D; Soliman, MA; Zaghloul, H1
Baek, EJ; Kim, KI; Kim, MJ1

Reviews

1 review(s) available for dextrothyroxine and ribavirin

ArticleYear
Antiviral treatment in COVID-19: which is the most promising?-a narrative review.
    Annals of palliative medicine, 2021, Volume: 10, Issue:1

    Topics: Adenosine Monophosphate; Alanine; Amides; Antibodies, Monoclonal, Humanized; Antiviral Agents; Azetidines; Chloroquine; COVID-19; COVID-19 Serotherapy; Drug Combinations; Humans; Hydroxychloroquine; Immunization, Passive; Indoles; Interferons; Ivermectin; Lopinavir; Nitro Compounds; Oseltamivir; Purines; Pyrazines; Pyrazoles; Ribavirin; Ritonavir; Sulfonamides; Thiazoles

2021

Trials

1 trial(s) available for dextrothyroxine and ribavirin

ArticleYear
Effect of a combination of nitazoxanide, ribavirin, and ivermectin plus zinc supplement (MANS.NRIZ study) on the clearance of mild COVID-19.
    Journal of medical virology, 2021, Volume: 93, Issue:5

    Topics: Adult; Antimetabolites; Antiparasitic Agents; COVID-19 Drug Treatment; Female; Humans; Ivermectin; Male; Nitro Compounds; Ribavirin; SARS-CoV-2; Thiazoles; Trace Elements; Zinc

2021

Other Studies

4 other study(ies) available for dextrothyroxine and ribavirin

ArticleYear
In vivo quantitative high-throughput screening for drug discovery and comparative toxicology.
    Disease models & mechanisms, 2023, 03-01, Volume: 16, Issue:3

    Topics: Animals; Caenorhabditis elegans; Drug Discovery; High-Throughput Screening Assays; Humans; Proteomics; Small Molecule Libraries

2023
DRESS syndrome with suspected Strongyloides infection in a patient treated for hepatitis C.
    Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology, 2013, Volume: 111, Issue:2

    Topics: Animals; Antiparasitic Agents; Antiviral Agents; Drug Hypersensitivity; Eosinophilia; Hepatitis C; Humans; Interferon alpha-2; Interferon-alpha; Ivermectin; Male; Middle Aged; Oligopeptides; Prednisone; Recombinant Proteins; Ribavirin; Strongyloides; Strongyloidiasis; Syndrome

2013
Evaluation of cytotoxicity and antiviral activity of ivermectin against Newcastle disease virus.
    Pakistan journal of pharmaceutical sciences, 2015, Volume: 28, Issue:2

    Topics: Animals; Antiviral Agents; Cell Line; Cell Survival; Chick Embryo; Ivermectin; Newcastle disease virus; Ribavirin

2015
In vitro and in vivo evaluation of the antiviral activity of arctigenin, ribavirin, and ivermectin against viral hemorrhagic septicemia virus infection.
    Fish & shellfish immunology, 2023, Volume: 132

    Topics: Animals; Antiviral Agents; Fish Diseases; Flounder; Hemorrhagic Septicemia, Viral; Ivermectin; Novirhabdovirus; Ribavirin

2023